Angela Tincani
Angela Tincani
professore reumatologia Brescia
Email verificata su med.unibs.it
Titolo
Citata da
Citata da
Anno
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis, MD Lockshin, T Atsumi, DW Branch, RL Brey, R Cervera, ...
Journal of Thrombosis and Haemostasis 4 (2), 295-306, 2006
61592006
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
R Cervera, JC Piette, J Font, MA Khamashta, Y Shoenfeld, MT Camps, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2002
18702002
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including …
GK Bertsias, JPA Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, ...
Annals of the rheumatic diseases 67 (2), 195-205, 2008
8232008
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
R Cervera, R Serrano, GJ Pons-Estel, L Ceberio-Hualde, Y Shoenfeld, ...
Annals of the rheumatic diseases 74 (6), 1011-1018, 2015
677*2015
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice
JC Souberbielle, JJ Body, JM Lappe, M Plebani, Y Shoenfeld, TJ Wang, ...
Autoimmunity reviews 9 (11), 709-715, 2010
6112010
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for …
GK Bertsias, JPA Ioannidis, M Aringer, E Bollen, S Bombardieri, IN Bruce, ...
Annals of the rheumatic diseases 69 (12), 2074-2082, 2010
5992010
Anti-inflammatory and immunosuppressive drugs and reproduction
M Østensen, M Khamashta, M Lockshin, A Parke, A Brucato, H Carp, ...
Arthritis research & therapy 8 (3), 209, 2006
5672006
Risk of congenital complete heart block in newborns of mothers with anti‐Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women
A Brucato, M Frassi, F Franceschini, R Cimaz, D Faden, MP Pisoni, ...
Arthritis & Rheumatism 44 (8), 1832-1835, 2001
5022001
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
CG Skorpen, M Hoeltzenbein, A Tincani, R Fischer-Betz, E Elefant, ...
Annals of the rheumatic diseases 75 (5), 795-810, 2016
4882016
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies
N Agmon-Levin, J Damoiseaux, C Kallenberg, U Sack, T Witte, M Herold, ...
Annals of the rheumatic diseases 73 (1), 17-23, 2014
4142014
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies
M Mosca, C Tani, M Aringer, S Bombardieri, D Boumpas, R Brey, ...
Annals of the rheumatic diseases 69 (7), 1269-1274, 2010
3892010
Antiphospholipid syndrome
R Cervera
Thrombosis research 151, S43-S47, 2017
379*2017
Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered β2‐glycoprotein I
N Di Simone, PL Meroni, N Del Papa, E Raschi, D Caliandro, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2000
3422000
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and …
L Andreoli, GK Bertsias, N Agmon-Levin, S Brown, R Cervera, ...
Annals of the rheumatic diseases 76 (3), 476-485, 2017
3332017
Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through …
N Del Papa, L Guidali, A Sala, C Buccellati, MA Khamashta, K Ichikawa, ...
Arthritis and rheumatism 40 (3), 551-561, 1997
3211997
Statins prevent endothelial cell activation induced by antiphospholipid (anti–β2‐glycoprotein I) antibodies: Effect on the proadhesive and proinflammatory phenotype
PL Meroni, E Raschi, C Testoni, A Tincani, G Balestrieri, R Molteni, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2001
3102001
Euro-Phospholipid Project Group. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
R Cervera, JC Piette, J Font, MA Khamashta, Y Shoenfeld, MT Camps, ...
Arthritis Rheum 46 (4), 1019-1027, 2002
3002002
Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies
G Reber, J Arvieux, E Comby, D Degenne, P De Moerloose, M Sanmarco, ...
Thrombosis and haemostasis 73 (03), 444-452, 1995
293*1995
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
A Fanouriakis, M Kostopoulou, A Alunno, M Aringer, I Bajema, JN Boletis, ...
Annals of the rheumatic diseases 78 (6), 736-745, 2019
2752019
Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical …
C Alessandri, M Bombardieri, N Papa, M Cinquini, L Magrini, A Tincani, ...
Annals of the rheumatic diseases 63 (10), 1218-1221, 2004
2582004
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20